ZTS Zoetis Inc.

NYSE zoetis.com


$ 145.47 $ 0.25 (0.17 %)    

Wednesday, 29-Oct-2025 10:37:02 EDT
QQQ $ 636.45 $ 0.91 (0.14 %)
DIA $ 479.45 $ 0.86 (0.18 %)
SPY $ 688.84 $ 0.07 (0.01 %)
TLT $ 91.73 $ -0.15 (-0.16 %)
GLD $ 369.55 $ 0.09 (0.02 %)
$ 145.41
$ 144.98
$ 145.41 x 201
$ 145.50 x 6
$ 144.49 - $ 146.08
$ 138.77 - $ 182.19
2,934,392
na
64.44B
$ 0.84
$ 24.67
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-K
4 11-04-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-13-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-14-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-15-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-16-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-13-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-06-2019 08-06-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-14-2019 12-31-2018 10-K
28 11-01-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-15-2018 12-31-2017 10-K
32 11-02-2017 10-01-2017 10-Q
33 08-08-2017 07-02-2017 10-Q
34 05-04-2017 04-02-2017 10-Q
35 02-16-2017 12-31-2016 10-K
36 11-03-2016 10-02-2016 10-Q
37 08-05-2016 07-03-2016 10-Q
38 05-06-2016 04-03-2016 10-Q
39 02-24-2016 12-31-2015 10-K
40 11-05-2015 09-27-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zoetis-portela-granted-european-commissions-marketing-authorization

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovet...

 zoetis-stock-outlook-remains-muted

Adhishthana.com analysis reveals why Zoetis stock may remain sluggish through June 2026, as weak triads weigh on its final phase.

 ubs-maintains-neutral-on-zoetis-lowers-price-target-to-158

UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target from $165 to $158.

 zoetis-announces-committee-for-veterinary-medicinal-products-of-the-ema-has-adopted-a-positive-opinion-recommending-the-granting-of-marketing-authorization-for-lenivia-for-the-reduction-of-pain-associated-with-osteoarthritis-in-dogs

Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) ...

 fda-conditionally-approves-first-drug-for-prevention-and-treatment-of-new-world-screwworm-infestations-in-cattle

https://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-drug-prevention-and-treatment-new-world-sc...

 zoetis-receives-positive-opinion-from-cvmp-for-portela-to-alleviate-pain-associated-with-osteoarthritis-in-cats

https://www.ema.europa.eu/en/news/meeting-highlights-committee-veterinary-medicinal-products-cvmp-9-10-september-2025

 argus-research-reiterates-buy-on-zoetis-maintains-190-price-target

Argus Research analyst Jasper Hellweg reiterates Zoetis (NYSE:ZTS) with a Buy and maintains $190 price target.

Core News & Articles

https://www.sec.gov/Archives/edgar/data/1767640/000101143825000442/xslForm13F_X02/informationtable.xml

 piper-sandler-maintains-overweight-on-zoetis-raises-price-target-to-215

Piper Sandler analyst David Westenberg maintains Zoetis (NYSE:ZTS) with a Overweight and raises the price target from $210 t...

 zoetis-files-for-mixed-shelf-size-not-disclosed

- SEC Filing 

 zoetis-lifts-outlook-as-companion-animal-portfolio-offsets-librela-decline

Zoetis beats Q2 estimates with strong pet product sales and raises full-year guidance despite livestock sales decline and Libre...

 zoetis-raises-fy2025-adj-eps-guidance-from-620-630-to-630-640-vs-623-est-raises-fy2025-sales-guidance-from-9425b-9575b-to-9450b-9600b-vs-9489b-est

FINANCIAL GUIDANCEZoetis is raising its full year 2025 guidance due to a strong first-half performance and continued discipline...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION